共 50 条
Effect of Biologic Therapies on Airway Hyperresponsiveness and Allergic Response: A Systematic Literature Review
被引:9
|作者:
Spahn, Joseph
[1
,11
]
Brightling, Christopher E.
[2
]
O'Byrne, Paul M.
[3
,4
]
Simpson, Lisa J.
[5
]
Molfino, Nestor A.
[6
]
Ambrose, Christopher S.
[7
]
Martin, Neil
[2
,8
]
Hallstrand, Teal S.
[9
,10
]
机构:
[1] AstraZeneca, Resp & Immunol, BioPharmaceut Med, Wilmington, DE USA
[2] Univ Leicester, Inst Lung Hlth, NIHR Leicester Biomed Res Ctr, Dept Resp Sci, Leicester, England
[3] McMaster Univ, St Josephs Hosp, Firestone Inst Resp Hlth, Hamilton, ON, Canada
[4] McMaster Univ, Dept Med, Hamilton, ON, Canada
[5] PharmaGenesis London, London, England
[6] Amgen Inc, Global Dev, Thousand Oaks, CA USA
[7] AstraZeneca, Resp & Immunol, BioPharmaceut Med, Gaithersburg, MD USA
[8] AstraZeneca, Resp & Immunol, BioPharmaceut Med, Cambridge, England
[9] Univ Washington, Div Pulm Crit Care & Sleep Med, Seattle, WA USA
[10] Univ Washington, Ctr Lung Biol, Dept Med, Seattle, WA USA
[11] 1800 Concord Pike, Wilmington, DE 19803 USA
来源:
JOURNAL OF ASTHMA AND ALLERGY
|
2023年
/
16卷
关键词:
airway hyperresponsiveness;
allergic response;
biologic;
systematic review;
asthma;
randomized placebo-controlled trial;
TUMOR-NECROSIS-FACTOR;
ANTI-TSLP ANTIBODY;
MONOCLONAL-ANTIBODY;
INDUCED BRONCHOCONSTRICTION;
SMOOTH-MUSCLE;
DOUBLE-BLIND;
MAST-CELLS;
ASTHMA;
OMALIZUMAB;
INFLAMMATION;
D O I:
10.2147/JAA.S410592
中图分类号:
R392 [医学免疫学];
学科分类号:
100102 ;
摘要:
Funding This study was funded by AstraZeneca and Amgen Inc.
引用
收藏
页码:755 / 774
页数:20
相关论文